Medtronic & #039;s New Diabetes App Is Next-Level Personalized Care

Diabetes is among the most data-intensive chronic conditions that exist today, which is why so many digital health technology companies are clamoring to be part of the solution for the millions of people living with the condition.  And as MD+DI explored earlier this year, one of the keys to succeeding in the diabetes device space is a readiness to innovate. Also, a keen eye for strategic partnerships is a big plus. Medtronic has proved time after time that it is capable of both, and its partnership with Tel Aviv, Israel-based Nutrino is the latest example of that. Medtronic updated its iPro2 myLog app with FoodPrint report. The iPro2 myLog app is designed to give clinics a simple way to import patients' logged data during their professional iPro2 continuous glucose monitoring (CGM) evaluation. With the addition of Nutrino's FoodPrint report, patients' meals are graded based on their body's unique glucose reaction, making it easy for them to understand the link between meals and glucose variability, the company said. The iPro2 myLog app, now powered by Nutrino, an artificial intelligence personalized nutrition analysis platform, is used during a professional iPro2 CGM evaluation for the patient to log their blood glucose, food, and activity. Patients are able to log what they eat simply by taking a photo of each meal and snack. After the six-day CGM evaluation, the information from the app is synchronized with sensor glucose data and creates two unique reports, the Patt...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news